Nurse Practitioner in Rockland, ME Accepting Medicare

6 Nurse Practitioner nurses found. Showing 1 - 6

Whitney Tranchemontagne, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 22 White St Ste 101, Rockland, ME 04841 Phone: 207-301-6000    Fax: 207-301-5106

Deborah Mackinnon, Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 12 Union St, Rockland, ME 04841 Phone: 207-701-4400    Fax: 207-701-4486

Dawn M Murphy, CRNP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 4 White St, Rockland, ME 04841 Phone: 207-594-6763    Fax: 207-594-6741

Mr. Christian Ian Macfee, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 12 Union St, Rockland, ME 04841 Phone: 207-701-4400

Susan R Lord, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 22 White St, Rockland, ME 04841 Phone: 207-594-3114    Fax: 207-594-3108

Vanessa Shields-haas, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 22 White Street, Rockland, ME 04841 Phone: 207-922-3222

News Archive

Health law: Senate Judiciary hearing offers preview of possible Supreme Court arguments

Senate Democrats held a hearing Wednesday at which Senators and witnesses debated the constitutionality of the health overhaul.

Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

Though there has been considerable biological and political debate over the use of embryonic stem cells (ESCs) vs. adult stem cells (ASCs) as therapies for tissue engineering and organ transplants, inherent benefits and drawbacks in both techniques compel them to coexist and complement each other.

NHI leases Suite Living Senior Specialty Services for $4.2M

National Health Investors, Inc. announced today new investments totaling $7.2 million. The transactions include a purchase/leaseback of a 24-unit assisted living and memory care facility in Minnesota with Suite Living Senior Specialty Services (formerly known as Comforts of Home) for $4.2 million and the origination of a $3.0 million second mortgage secured by interests in three skilled nursing facilities in Texas totaling 311 beds as part of a bridge to HUD financing for the borrower.

AstraZeneca is developing new PARP inhibitor for treatment of ovarian cancer

The ovarian cancer market is highly active with several promising candidates having reached the late stages of development. Three PARP inhibitors, Lynparza (AstraZeneca), niraparib (Tesaro) and rucaparib (Clovis Oncology), which induce cell death in mutated [BRCA-deficient] cancer cells, have been identified by Datamonitor Healthcare as front runners.

Shire announces update on approval status and availability of ProAmatine SOH drug

Shire plc, the global specialty biopharmaceutical company, announces an update on the approval status and availability of ProAmatine (midodrine HCl), a medicine approved for the treatment of symptomatic orthostatic hypotension.

Read more Medical News

› Verified 1 days ago